Kansas City, KS- From more flexible donor matching in bone marrow transplants to groundbreaking immunotherapies like CRISPR-edited CAR-T, science is opening new doors to survival and long-term remission.
Amanda Sprinkle was diagnosed with leukemia in May 2023. She needed a bone marrow transplant to survive. Despite having more than two dozen potential matches, only one remained. That’s when her brother Jonathan, a professional baseball player and only a half-match, underwent advanced genetic testing—and turned out to be the best option. Thanks to new transplant protocols that make half-matched (haploidentical) donors a viable and often life-saving option, Jonathan’s donation led to Amanda’s recovery.
Amanda’s story is part of a new wave of innovation in blood cancer care. Another patient, Katie Kopp, successfully underwent CAR-T cell therapy enhanced with CRISPR gene editing, an advanced treatment that reprograms a patient’s own immune cells to recognize and destroy cancer. Katie is now cancer-free.
These cases highlight the rapid evolution of treatment for hematologic malignancies such as leukemia and lymphoma. The need for bone marrow donors remains critical—especially from family members or others willing to donate even if not a perfect match. As research continues to advance, more patients will have the opportunity to benefit from these life-saving therapies.
